Chart Global Biopharma Financing Hit a 4-Year High in Q4 2025, Fueled by $200bn in Pharma M&A 8 September 2026
Content China Biopharma Out-Licensing Surges to Record $137.7B in 2025, 2026 on Pace to Break It Again 20 February 2026
